In response to continuing success of their novel large particle flow cytometer, BennuBio has moved to a larger facility to consolidate engineering, administrative and laboratory in one building. Formerly located in the WESST Enterprise Center, and with shared laboratory space at TriCore Reference Laboratories, BennuBio is now located at 6610 Gulton Ct. NE in Albuquerque.
CEO, Steven Graves stated, “A larger facility is fundamental in supporting the rapidly expanding commercialization efforts for our instrument, the Velocyt. It also provides the additional space we’ll need for potential collaboration partners that have expressed interest in our ground-breaking technology.”
BennuBio is developing a revolutionary flow cytometry instrument with the capability of analyzing 3D tissue models which play an increasingly important role in personalized medicine, cancer, and immunotherapy research. The foundational technology was licensed from the University of New Mexico and is being further enhanced and developed with funding from Tramway Venture Partners, Cowin Venture, Cottonwood Technology Fund, and Sun Mountain Capital.
The expansion sets the stage for the growth of the company’s staff.